CNN
—
Pfizer and BioNTech announced Friday that the US Food and Drug Administration has granted priority review designation to the companies’ application for approval of their Covid-19 vaccine. The goal date for a decision from the FDA is January 2022, the companies said.
The typical priority review process allows six months, but FDA approval could come before the goal date.
Andy Slavitt, former White House senior adviser for the Covid-19 response, told CNN earlier this month that approval could happen in July, but acknowledged it’s a complex process.
“There’s a lot of moving pieces. It’s not as easy,” Slavitt told CNN’s Alisyn Camerota. “Hopefully in the next four to five weeks, and I think that will be very, very good news.”
Pfizer and BioNTech completed the rolling submission for the vaccine’s Biologics License Application for people ages 16 and older in May.
THIS IS A BREAKING NEWS STORY.